Biosynex S.A.
ALBIO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €50,500 | €47,500 | €53,700 | €50,325 |
| % Growth | 6.3% | -11.5% | 6.7% | – |
| Cost of Goods Sold | €50,800 | €48,499 | €64,300 | €24,664 |
| Gross Profit | -€300 | -€9,400 | -€10,600 | €25,661 |
| % Margin | -0.6% | -19.8% | -19.7% | 51% |
| R&D Expenses | €0 | €0 | €1,978 | €1,396 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €25,374 | €19,342 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €500 | €16,148 | -€2,478 | €42,327 |
| Operating Expenses | €500 | €16,148 | €24,874 | €63,065 |
| Operating Income | -€800 | -€10,000 | -€11,100 | -€37,404 |
| % Margin | -1.6% | -21.1% | -20.7% | -74.3% |
| Other Income/Exp. Net | -€49,700 | €0 | €0 | €17,658 |
| Pre-Tax Income | -€50,500 | €0 | €0 | -€19,746 |
| Tax Expense | -€1,900 | €1,300 | €100 | -€1,977 |
| Net Income | -€48,600 | -€22,300 | -€21,000 | -€17,553 |
| % Margin | -96.2% | -46.9% | -39.1% | -34.9% |
| EPS | -3.75 | -1.72 | -1.93 | -1.54 |
| % Growth | -118% | 10.9% | -25.3% | – |
| EPS Diluted | -3.75 | -1.72 | -1.93 | -1.54 |
| Weighted Avg Shares Out | 12,972 | 12,972 | 10,812 | 11,422 |
| Weighted Avg Shares Out Dil | 12,972 | 12,972 | 10,812 | 11,422 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | -€270 |
| Interest Expense | €4,100 | €4,500 | €1,700 | €1,271 |
| Depreciation & Amortization | €0 | €2,495 | €16,904 | €7,535 |
| EBITDA | -€1,000 | -€9,205 | -€1,254 | -€10,222 |
| % Margin | -2% | -19.4% | -2.3% | -20.3% |